We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

STN-Stimulation Versus Best Medical Treatment in Advanced PD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00196911
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : November 30, 2006
Information provided by:
German Parkinson Study Group (GPS)

September 11, 2005
September 20, 2005
November 30, 2006
January 2001
Not Provided
  • Quality of life
  • Motor Score in the OFF (UPDRS III)
Same as current
Complete list of historical versions of study NCT00196911 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
STN-Stimulation Versus Best Medical Treatment in Advanced PD
Randomized, Multicenter, Prospective, Parallel-Group Study of the Effect of Deep Brain Stimulation (Subthalamic Nucleus) on Quality of Life and Motor Complications in Patients With Advanced Parkinson's Disease Compared With Best Medical Treatment
Assessment of the therapeutic effect of deep brain stimulation of the subthalamic nucleus compared with drug treatment alone in patients with advanced Parkinson's disease.
Patients are randomized either to medical treatment or subthalamic stimulation. The observation period was 6 months. The primary outcome criterium: PDQ-39 and UPDRS III.
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Parkinson's Disease
Procedure: Implantation of stimulation electrodes in the STN
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
January 2005
Not Provided

Inclusion Criteria:

advanced Parkinson's disease with UPDRS III score >29/104 or Dyskinesia score > 2 or tremor >2

Exclusion Criteria:

age>75 years depression psychosis surgical contraindications

Sexes Eligible for Study: All
20 Years to 75 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
A 125/00
Grant 01 GI 0201/01 GI 0401
Not Provided
Not Provided
Not Provided
Not Provided
German Parkinson Study Group (GPS)
Not Provided
Principal Investigator: Guenther Deuschl, Prof. Department of Neurology, Christian-Albrechts University
German Parkinson Study Group (GPS)
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP